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Abstract
Rev is an essential regulatory protein in the equine infectious anemia virus (EIAV) and other lentiviruses, including HIV-1. It
binds incompletely spliced viral mRNAs and shuttles them from the nucleus to the cytoplasm, a critical prerequisite for the
production of viral structural proteins and genomic RNA. Despite its important role in production of infectious virus, the
development of antiviral therapies directed against Rev has been hampered by the lack of an experimentally-determined
structure of the full length protein. We have used a combined computational and biochemical approach to generate and
evaluate a structural model of the Rev protein. The modeled EIAV Rev (ERev) structure includes a total of 6 helices, four of
which form an anti-parallel four-helix bundle. The first helix contains the leucine-rich nuclear export signal (NES). An
arginine-rich RNA binding motif, RRDRW, is located in a solvent-exposed loop region. An ERLE motif required for Rev activity
is predicted to be buried in the core of modeled structure where it plays an essential role in stabilization of the Rev fold. This
structural model is supported by existing genetic and functional data as well as by targeted mutagenesis of residues
predicted to be essential for overall structural integrity. Our predicted structure should increase understanding of structure-
function relationships in Rev and may provide a basis for the design of new therapies for lentiviral diseases.
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Introduction
Equine infectious anemia virus (EIAV) is a member of the
lentivirus subfamily of retroviruses, which includes several
important pathogens of humans and domestic animals, including
HIV-1, the causative agent of AIDS [1–3]. Lentiviruses exploit
differential and alternative splicing, and overlapping reading
frames to generate the proteins necessary for maintaining their life
cycles [2,4]. Fully spliced viral mRNAs produced during the early
phase of replication encode regulatory proteins such as Rev and
Tat [2]. Incompletely spliced mRNAs give rise to structural
proteins, including Pol and Gag that are required for replication
and packaging of the viral genome. Rev is a small RNA-binding
protein essential for exporting these incompletely spliced mRNAs
to the cytoplasm. Export is initiated by the binding of Rev to a
specific Rev-responsive element (RRE) in the viral pre-mRNA
[2,5,6]. The Rev-mRNA complex is then exported to the
cytoplasm by interaction of the nuclear export signal (NES) of
Rev with CRM1 (or exportin 1), a component of the cellular
nuclear export machinery [7–10]. Rev itself shuttles back into the
nucleus using the interaction of its nuclear localization signal
(NLS) with cellular nuclear import proteins [11–13]. Mutations in
either the NES or NLS can abolish Rev function and block the
production of infectious virus [14–16]. Although Rev has long
been viewed as a promising target for antiviral therapies, the
development of drugs that inhibit Rev function has been hindered
by a lack of information regarding Rev structure. The principal
stumbling block to structure determination is the tendency of Rev
to aggregate at concentrations needed for crystallization or solution
NMR studies [17–19]. In HIV-1, beyond a critical threshold of
about 6 uM, Rev polymerizes into regular, unbranched filaments
[18]. Recent solid state nuclear magnetic resonance (NMR) study
on HIV-1 Rev filaments and Rev-RNA co-assembly suggested that
although their morphologies are qualitatively different, protein
conformations in each assembly are the same, supporting the
previous helix-loop-helix structural model [20]. However, so far,
the only available high-resolution structure is an NMR solution
structure of a 23 amino acid fragment of Rev bound to a 34-
nucleotide RRE-RNA fragment [21].
Previously, we have investigated the role of genetic variation in
EIAV persistence and pathogenesis [22–25]. One of the most
variable regions in the EIAV genome is in the region where the
Rev gene overlaps sequences encoding the cytoplasmic portion of
the transmembrane protein [23]. Recent studies have focused on
mapping the functional domains of EIAV Rev (ERev) shown in
Fig. 1 [25,26] and determining the effect of genetic variation on
Rev activity [24,27]. As part of those efforts, we sought to develop
a structural model of ERev.
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proach to propose and evaluate a three-dimensional structural
model of the ERev protein. We adopted a structural threading
scheme that focuses on structural similarities with minimal reliance
on sequence homology, a strategy that is useful when sequence
similarity is weak or undetectable (sequence identity ,25%) [28].
We evaluated the validity of the proposed ERev model in the
context of previously published genetic and functional data and
tested specific predictions of the model by assaying the effects of
amino acid substitutions on Rev activity in transient expression
assays. These approaches, together with a comparative analysis of
the EIAV and FIV Rev structures, support the validity of the
proposed three-dimensional structure of ERev. The model
provides insight into the structural basis of Rev function that
may increase understanding of CRM1 dependent export proteins
in a number of virus species.
Results and Discussion
Structural model of EIAV Rev
In the threading studies, fragments of the ERev protein have
been threaded against 13,391 representative structures in the
structural template library, and the model structures were
obtained from the top scoring members of the top five families
using MODELLER [29,30] (see Materials and Methods).
The results of the threading on top five template structures and
their secondary structure composition in each model are shown in
Table 1. The best score of 37 was obtained from the threading of a
fragment of ERev corresponding to amino acids 31–145 against
the region corresponding to amino acids 1,075–1,200 of the
structure of an N-terminally truncated rat serum complement C3d
fragment [31] (PDB code 1qsj chain D). The family to which
1qsjD belongs had 6 members and all of them gave the threading
score greater than the threshold. The next four templates gave
much lower threading scores, ranging from 28 to 31. The
secondary structure composition of the top model was the average
of the predicted secondary structure composition by Prof and
Psipred. In two of the four alternative folds (template 1iar and
1hc1), the secondary structure composition from the model was
also the average of the predicted secondary structure using Prof
and Psipred. In the other two alternative models, the secondary
structure composition from the model was significantly different
from those of predicted versions. In Fig. 2, the sequence alignment
between the ERev and the best scoring template is shown along
with the secondary structures obtained from the model, template
structure, and that predicted using Prof. The secondary structure
obtained from the model agrees well with the predicted one. With
the significant threading score as well as a good agreement with
the predicted secondary structure, the top model was selected for
further analysis.
A full atomistic model of the top model is shown in Fig. 3A. The
region containing amino acids 31–145 consists of five helices, four
of which are configured in a four-helix bundle (helix 1 to helix 4).
The first 30 residues of ERev, corresponding to exon 1, were not
modeled in our experiments; however, exon 1 sequences are not
required for Rev function [11]. A structure of the full-length Rev
exon 2 (a.a. 31–165), including the C’terminal RNA-binding/NLS
region, yielded a lower threading score against the same template
(PDB code 1qsj). The major difference in the alignment occurred
starting from amino acid position 95 and there was shift in the
alignment in the fifth helix. The model structure for the full-length
exon 2 Rev sequence is shown in Fig. 3C. Despite the difference in
the alignment in the fifth helix, the overall topology of the full-
length Rev exon 2 is very similar to that of the truncated version
(a.a. 31–145) shown in Fig. 3A.
EIAV Rev structural model is consistent with genetic
analyses of functional domains
To determine if the structural model was consistent with
previously published genetic data of Rev functional domains, we
mapped the known functional and/or essential domains of ERev
onto the three-dimensional structural models of truncated and full-
length Rev exon 2 (Fig. 3B and C). The leucine-rich nuclear
export signal (NES) is located in the first helix of our model
(Fig. 3B). The NES interacts with CRM1 to effect export of
incompletely spliced RNA to the cytoplasm [8,10], and the
sidechains of the four hydrophobic residues required for NES
activity (L36, W41, L45, L49) are directed outward in our model.
The solvent accessible surface area (ASA) associated with three of
these four hydrophobic residues is very high (26.6–57.3%), which
is consistent with their role in mediating protein-protein
interaction with CRM1. L36 is highly buried (ASA=0.9%) due
to its contact with L90, but it is feasible that this contact may be
disrupted upon Rev-RNA binding.
The RNA-binding domain of ERev is comprised of two short,
discontinuous motifs: RRDRW (a.a. 76–80) in the central region
Figure 1. The sequence and functional domain organization of ERev. (A) The amino acid sequence of ERev variant R1: a representative
sequence used in the threading study. (B) Functional domain organization of ERev.
doi:10.1371/journal.pone.0004178.g001
Structural Model of EIAV Rev
PLoS ONE | www.plosone.org 2 January 2009 | Volume 4 | Issue 1 | e4178of ERev, and the C’terminal KRRRK (a.a. 159–163) [26]. The
KRRRK motif is also required for nuclear import [26]. The
arginine-rich RRDRW motif, represented in red ball-and-stick in
Fig. 3B and C, is located in a solvent-exposed loop connecting the
second and third helices. The KRRRK motif is juxtaposed with
arginine-rich RRDRW motif on the surface of the folded structure
corresponding to the complete exon 2 Rev sequence (Fig. 3C).
Although the full length exon 2 model structure containing the
KRRRK region is not well justified by significant threading score,
it suggests the possibility that RRDRW and KRRRK motif
together may form a single continuous arginine-rich motif on the
surface of Rev structure, making the interaction with RNA
favorable.
Mutations and/or deletions in the central regions of ERev exon
2 have been shown to significantly reduce Rev nuclear export
activity [8,25,27,32]. Alanine substitution of an ERLE motif in the
central region (a.a. 93–96) abrogated Rev nuclear export activity,
and this motif was previously proposed as an RNA binding
domain [8,32]. More recently, however, we found no decrease in
RNA binding when alanine was substituted for only the charged
residues in the ERLE motif [26]. In contrast to RRDRW, the ASA
calculations based on our model indicate the ERLE motif is very
much buried in the protein core of ERev (Table 2). In addition,
two residues in this motif are predicted to make contacts important
for stabilization of the structure: L95 makes several inter-helical
hydrophobic contacts (see below) and the R94 forms a salt bridge
with D39. When considered with our experimental RNA binding
studies [26], the structural model supports a role for ERLE in
maintaining the structural integrity of ERev essential for Rev
function in vivo. In addition, these results indicate that appropri-
ately folded structure of Rev is required for RNA binding.
The structural model is supported by targeted
mutagenesis of critical residues
In order to further validate the model structure, we sought to
identify specific residues expected to be most important for the
structural integrity of ERev. For this, we obtained inter-helical
hydrophobic contact information for each residue in ERev model
Table 1. Results of the threading on top five template structures and their secondary structures.
Aligned region
(a.a.)
Template
PDBID
Threading
score S.S. using model (a, b, coil)
a S.S using Prof (a, b, coil) S.S using Psipred (a, b, coil)
31–145 1qsj 37 (59, 0, 41) (54, 2, 44) (63, 0, 37)
31–150 1iar 31 (57, 0, 43) (52, 1, 47) (61, 0, 39)
1–140 1occ 28 (46, 0, 54) (56, 2, 42) (60, 2, 38)
36–155 1hc1 28 (58, 0, 42) (52, 1, 47) (61, 2, 37)
66–145 1bxr 28 (53, 0, 47) (60, 2, 38) (70, 0, 30)
aPercentage of alpha helix, beta strand, and coil.
doi:10.1371/journal.pone.0004178.t001
Figure 2. The sequence and secondary structure alignments based on threading. The sequence alignment between the ERev (R1) and the
best scoring template (1qsjD), along with the secondary structures obtained from the model (S.S. of R1), template structure (S.S. of 1qsjD), and that
predicted using Prof.
doi:10.1371/journal.pone.0004178.g002
Structural Model of EIAV Rev
PLoS ONE | www.plosone.org 3 January 2009 | Volume 4 | Issue 1 | e4178structure. Inter-helical contact analysis revealed that three
residues, L65, L95, and L109, participate in more than three
inter-helical hydrophobic contacts in the model structure.
Interestingly, L95 is located within the ERLE motif discussed
above. The inter-helical contact and ASA data associated with
these residues are shown in Table 2, and the three residues are
represented in space-fill in Fig 4B. The ASA values for L95 and
L109 are close to 0%, and that of L65 is 5.7%. This suggested that
L95 and L109 might make the most important hydrophobic
contact to stabilize the Rev structure and the structural
importance of L65 would be of lesser significance.
To test this hypothesis, mutations were introduced at each of the
three sites, and the effect of mutations was assessed using CAT-
based transient expression assay. The mutation strategy was based
on that introduced by Thomas and coworkers to test the structural
roles of selected amino acids in HIV-1 Rev [33]. In order to test
the structural importance of selected residues, they first mutated
those individual residues to aspartic acid, which are incompatible
with formation of buried hydrophobic contacts. The mutation
effect on Rev structure, which is destabilization of the protein
structure, is manifest as a dramatic reduction in Rev activity in
CAT-based assays. As a second step, in order to directly test
residue contacts, they introduced both individual single alanine
mutations and simultaneous double alanine mutation to residue
pairs predicted to be in contact. Because proteins have inherent
flexibility, the cavity created by single alanine mutation will be
filled by the compensatory rearrangement of surrounding residues.
In contrast, the cavity created by simultaneous double alanine
mutation cannot be compensated, which severely destabilizes the
protein structure and results in reduction in Rev activity. The
analysis of such double mutations should indicate which predicted
inter-helical contacts are most important for stabilizing Rev
structure and maintaining full Rev activity. Using the same
mutational strategy, mutations were introduced into the ERev
protein and the effect of mutations was evaluated in a Rev nuclear
export activity assay (Fig 4A). As expected, Asp mutations on L95
and L109 significantly reduced nuclear export activity, indicating
that these residues play critical roles in stabilizing the ERev
structure. A less critical role for L65 was supported by
maintenance of 50% of Rev activity in L65D. Further, disruption
of the hydrophobic contact between L95 (within the ERLE motif
in helix 3) and L109 (within helix 4) introduced by L95A/L109A
double Ala mutation completely abrogated nuclear export activity.
This suggests that inter-helical contact between these two amino
acids is critical for maintaining a functional Rev structure. In
contrast, the L65-L95 and L65-L109 contacts appear to have
negligible impact on Rev activity, indicating that these two
contacts are of less significance for the Rev structure. L65A/
L109A mutation showed no decrease, but rather an increase in
Rev activity by 49% compared with R1. It is likely that the
increase mainly occurred due to the stabilizing effect of L109A
mutation (see discussion below). The decrease of the Rev activity
upon L65A/L95A mutation (5%) was statistically insignificant.
Surprisingly, we observed significant increases in Rev activity
upon single Ala mutations at L95 and L109. The contact data
analysis revealed that L109 makes an intra-helical hydrophobic
contact with V112 in addition to four inter-helical hydrophobic
contacts with L65, L95, I99, and V102 (see Table S1 in
Supporting Information). Notably, three out of five contact
residues for L109 are beta-branched hydrophobic residues (I99,
V102, and V112). L95 makes an intra-helical hydrophobic contact
with L91 and three inter-helical hydrophobic contacts with L65,
L109, including a contact with beta-branched V112. Beta-
branched residues have limited sidechain rotational degree of
freedom due to the steric hindrance with i-3 and i-4 carbonyl
oxygens in g
+ rotamer state, and thus can cause distortion in local
helix backbone. The effects of beta-branched residues on alpha-
Table 2. Solvent accessible surface area (ASA) associated
with residues in the RRDRW and the ERLE motifs.
Residue (RRDRW) ASA (%) Residue (ERLE) ASA (%)
R76 32.8 E93 10.5
R77 65.6 R94 0.0
D78 19.5 L95 0.3
R79 62.1 E96 12.2
W80 26.4
ASA values were calculated using MOLMOL.
doi:10.1371/journal.pone.0004178.t002
Figure 3. Structural model of ERev. (A) The model of the truncated Rev exon2 (a.a. 31–145). (B) Known functional domains are mapped on the
model structure of the Rev exon2. The NES domain is colored in orange with four hydrophobic residues critical for export activity shown in space-fill.
The RRDRW RNA-binding motif is depicted in red ball-and-stick. The ERLE motif appears in green space-fill. (C) The model of the full-length Rev exon2
(a.a. 31–165). Basic residues in RRDRW and KRRRK motifs are depicted in red ball-and-stick.
doi:10.1371/journal.pone.0004178.g003
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destabilize helix propensity [34,35]. Contacts involving many
beta-branched hydrophobic residues in the crowded protein core
may generate strain in helices, destabilizing the structure.
Mutations that relieve this strain might be expected to increase
Rev activity. In order to test the strain effect on protein stability by
beta-branched residues, we introduced Ala mutation into V112.
The V112A mutation increased Rev activity to 117% of R1 Rev
activity (Fig. 4A), indicating that releasing strain can actually
increase Rev activity. A similar mechanism may account for the
increased Rev activity observed in L95A and 109A mutants.
The targeted mutagenesis of ERev, however, did not support
four alternative model structures (Table S2). L65, L95, and L109
in alternative models either reside in a loop or make insignificant
number of inter-helical hydrophobic contacts, ranging from 0 to 2,
if they reside in helices. While the total number of inter-helical
hydrophobic contacts made by these three residues was 10 in the
top model, those in the alternative models were in between 1 to 4.
This, together with the significantly higher threading score of the
top model and good agreement with the predicted secondary
structure supports our predicted model.
Our structural model provides new information on the
structural features of the NES domain that interacts with CRM1
as well as the RNA binding domain in the context of the entire
structure of the Rev exon 2. CRM1-dependent nuclear export is a
key step in the replication of many viruses, including retroviruses
and influenza viruses [36,37]. Our structural model will enhance
our studies on the structural basis of protein-protein interactions
required for successful virus replication and will provide aid in the
design of effective antiviral drugs. In addition, our model provides
structural information on the ‘‘hyper-variable’’ or ‘‘non-essential’’
region that was first identified by Belshan and co-workers [23].
The hyper-variable region, located in the loop connecting the
fourth and the fifth helices in our model, has been shown to be
dispensable for Rev activity, however, the high numbers of
mutations in this area can result in significant fluctuations in levels
of Rev activity in vitro. Our model provides structural basis on the
ability of the non-essential region in ERev to withstand a variety of
genetic variation. Identifying such non-essential loops in genes of
overlapping reading frames based on the model is very useful in
our ability to gain better understanding and control of the virus.
EIAV and FIV Rev share similar structural features
In addition to ERev, we also used our threading algorithm to
model the structure of Rev proteins from other lentiviruses,
including FIV Rev. For the FIV Rev, we obtained a significant
threading score for the region corresponding to amino acids 16–
145 against the structure of interleukin 4 structural mutant [38].
Interestingly, the modeled region of FIV Rev forms a four-helix
bundle with structural similarity to the region of helix 1 to helix 4
of ERev model structure (Fig. 5). Using Dali structure comparison
method [39], the structural similarity between the FIV and the first
four helices of EIAV Rev model structures was significant (CA
RMSD=2.8 A ˚). Although FIV Rev is not as well characterized as
ERev, the location of NES domain in our FIV Rev model is
Figure 4. Nuclear export activities of ERev mutant proteins. (A) The level of Rev nuclear export activity associated with single Ala, Asp
mutations, and double Ala mutations. The results are expressed relative to wildtype Rev variant R1, and represent the mean activity of at least six
independent transfections, 6standard error. Variants that differed significantly from the activity of R1, according to a two-tailed t-test, are indicated
by asterisks, *p,0.05; **p,0.005; ***p,0.0005. (B) Mutation sites are displayed in space-fill in the truncated Rev exon2 model structure.
doi:10.1371/journal.pone.0004178.g004
Table 3. Inter-helical hydrophobic contacts and solvent
accessible surface area in the truncated model structure of
ERev.
Residue
Number of inter-helical
hydrophobic contacts ASA (%)
L65 3 5.7
L95 3 0.3
L109 4 0.2
doi:10.1371/journal.pone.0004178.t003
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unusually large [9,10] and in our model extends from helix 3
through the loop connecting helix 3 and 4. Amino acids known to
be critical for protein-protein interaction with CRM1[10] are
facing outward. A highly basic domain (a.a. 83–94) that could play
a role as a RNA binding domain, is located in the region including
the C-terminal part of the loop connecting the second and third
helices and the N-terminal part of the third helix. Arginine and
lysine residues in this region are facing outward with high solvent
accessibility (ASA between 22–67%), similar to the situation in
ERev. The similarities in overall structure and spatial organization
of functional domains in ERev and FIV Rev occurred despite the
fact that they share insignificant sequence similarity (BLAST
alignment E-value=6.4). More extensive comparative structural
threading analysis, applied to both primate and non-primate
lentiviruses, may provide additional insight into common struc-
tural features important for Rev function.
Materials and Methods
Structural threading
In threading, a target protein sequence is aligned with a library
of structural templates from known structures in the Protein Data
Bank (PDB), and a sequence-to-structure alignment for each
template is evaluated to identify the fold with best ‘‘fit’’ [28,40,41].
In our approach [28], candidate structures are represented by
contact matrices, following the work of Miyazawa and Jernigan
[42]. The position of an amino acid sidechain is defined by the
average heavy atom position, referred to as the center of position
(COP). Two residues, i and j, are defined to be in contact (Cij=1),
if the distance between their COP’s is less than or equal to 6.5A ˚,
and not in contact (Cij=0), otherwise. For threading alignment,
initial profiles representing the template structures are generated
from the first four eigenvectors of the contact matrices. To predict
the structure for a target protein, its sequence is threaded against
all the structures in the structural template database in search of a
structure with a significant ‘‘fit’’ to the sequence. The structural
template database for threading consisted of 13,391 representative
structural domains selected from the Astral 1.61 domain library,
covering 1,939 families of SCOP domains [43,44]. Redundancy of
the database was reduced by including only 20 representative
structures for any family with more than 20 members. Otherwise,
all structures in each family were included in the database. The
strength of each alignment is determined by a scoring function
consisting of a sum of all residue-residue contacts. Hydrophobic
strengths are evaluated using the Li, Tang and Wingreen
parameterization [45] of the Miyazawa-Jernigan matrix [42].
Local secondary structure preference is incorporated by enhancing
the threading score if the predicted secondary structure of the
target protein sequence matches that of the template structure.
Secondary structure assignments for the template structures were
generated from their PDB coordinates using Stride software [46].
The input to the threading process is the sequence and
predicted secondary structure of the ERev protein. Although
there is a high rate of Rev variation in vivo, ERev amino acid
variants share over 92% sequence similarity among themselves
[27]. Rev variant R1, which was originally identified as the
dominant variant in a horse experimentally infected with the
virulent EIAVWyo2078 [23], was selected as a representative ERev
protein sequence. Secondary structure of the full length R1 Rev
sequence was predicted using three different methods, PSIPRED
[47], PROF [48], and Sam-T99. The final secondary structure
profile of the target sequence was assigned such that, for each
residue in the sequence, if the secondary structure prediction by
different servers agreed, the consensus of the prediction was
assigned as the secondary structure for the residue, otherwise, the
secondary structure was left unassigned. Prior to threading, the
ERev sequence was fragmented into overlapping segments with a
minimum length of 60 residues and with starting positions every 5
residues. The length of the fragments was also varied, from 60 a.a.
to full length (165 a.a.), in 5 residue increments. All fragments
generated in this manner were threaded against the 13,391
representative structures in the structural template library and the
threading score for each fragment was calculated. The threading
score, originally termed as the relative score in Cao et al. [28], is
defined by the difference between the raw threading score of the
Figure 5. Predicted structural model of FIV Rev protein compared with that of ERev. (A) FIV Rev model structure corresponding to the
region a.a. 16–145. The NES domain is shown in orange, with three hydrophobic residues critical for export activity shown in space-fill. Arginine and
lysine residues in a highly basic region that may play a role in RNA binding and nuclear import are shown in red ball-and-stick. (B) ERev model
structure containing helix 1 to helix 4. Four hydrophobic residues in NES domain are shown in orange space-fill representation, and arginine residues
in RRDRW motif are shown in red ball-and-stick. (C) The structure alignment between the FIV (green) and the ERev (purple) models. For clarity, only
the first four helices of the ERev model are shown. Also, all loops except the region between the RRDRW motif and the third helix of the ERev model
are not shown.
doi:10.1371/journal.pone.0004178.g005
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sequences. The significance of the threading was determined on
the family basis: if over 75% of the members in a family give the
threading scores above threshold, the alignment between the
sequence and the template structures from the family was
considered significant. Model structures from the top five families
were obtained from the alignments with the top scoring member of
the family. Details of the threading scheme are provided in Cao et
al. [28]. After threading, full atomistic models of the Rev protein
were generated from the template and alignment obtained from
the threading studies using the MODELLER [29,30], and NEST
software tool incorporated in JACKAL 1.5 [49].
Characterization of Rev structural mutants
Mutations predicted to specifically disrupt inter-helical contacts
or tertiary structure of ERev were introduced into the Rev
expression vector pcH21SL using PCR-based site-directed muta-
genesis
25. All mutations were confirmed by sequencing and Rev
nuclear export activity was quantified in transient transfection
assays using chloramphenicol acetyltransferase (CAT) reporter
plasmids containing EIAV RRE, as previously described [24].
Plasmids encoding wild-type Rev or Rev mutants were co-
transfected into HEK 293T/17 cells (293T, ATCC CRL-11268)
with 0.2 mg of EIAV RRE reporter plasmid and 0.2 mgo f
pCH110. Each experiment included a sham group that contained
no reporter plasmid, but an additional 0.2 mg of pUC19. Two
days post-transfection, cells were harvested, resuspended in 0.3 ml
0.25 M Tris (pH 7.5), lysed by freeze/thawing, and assayed for b-
galactosidase activity to normalize CAT assays for transfection
efficiency. Normalized lysates were assayed for CAT levels using a
CAT ELISA kit (Roche Applied Science). Each mutant was
assayed in triplicate and the results represent at least six
independent transfections normalized to wild-type Rev. Results
were analyzed using two-tailed Student’s t-test assuming unequal
variance among groups to detect significant differences between
mutants and wild-type Rev.
Supporting Information
Table S1 Inter-helical and intra-helical contacts associated with
selected residues in the truncated Rev exon2 model.
Found at: doi:10.1371/journal.pone.0004178.s001 (0.03 MB
DOC)
Table S2 Number of inter-helical hydrophobic contacts associ-
ated with selected residues in the top five model structures.
Found at: doi:10.1371/journal.pone.0004178.s002 (0.03 MB
DOC)
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